Logo

Pfizer

Pfizer Partners With Tempus to Advance Oncology Drug Development

Pfizer will have access to Tempus' artificial intelligence-powered platform, data library, companion diagnostics platform, and clinical trial matching program.

Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China

The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi.

EU Project Screen4Care Will Apply Sequencing, AI to Screen Newborns for Rare Diseases
Premium

The project involves numerous biopharmaceutical firms, including Pfizer, Roche, Takeda Pharmaceuticals, Sanofi, Novartis, ProQR Therapeutics, Lysogene, and Novo Nordisk.

Codex DNA Bets on Enzymatic Building Block Method for Gene Synthesis
Premium

The short oligo ligation assembly (SOLA) enzymatic DNA synthesis method uses a library of DNA building blocks to make oligos that are then assembled into genes.

Sema4 to Embrace Co-CEO Model After $623M Acquisition of GeneDx
Premium

The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.

Jan 18, 2022

Sema4 to Acquire GeneDx for $623M

Nov 30, 2021

Exact Sciences, Pfizer End Cologuard Copromotion Agreement

Jul 28, 2021

AbbVie, Biogen, Pfizer Join With Broad Institute on Genebass Exome Variant Project
Premium

Mar 2, 2021

Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Dec 7, 2020

UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects

Oct 30, 2020

Opko Health Q3 Revenues Up 87 Percent

Oct 29, 2020

Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

Nov 13, 2019

Pfizer Inks Deal for Access to Centogene Rare Disease Data

Sep 23, 2019

Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines
Premium

Jul 23, 2019

Pfizer, Syapse Ink Real-World Precision Oncology Collaboration

Jun 6, 2019

TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts
Premium

Jun 4, 2019

At ASCO, Real-World Data Shows Potential to Improve Precision Oncology
Premium

Apr 30, 2019

Exact Sciences Q1 Revenues Up 79 Percent

Jan 16, 2019

Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug

Oct 30, 2018

Exact Sciences Q3 Revenues Up 63 Percent

Oct 30, 2018

Precision Oncology Highlights From ESMO 2018

Oct 16, 2018

FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug

Oct 12, 2018

AmoyDx Lung Cancer CDx Approved in South Korea

Oct 10, 2018

Myriad Upgraded to Overweight by Piper Jaffray; Signs Lab Service Deal with Pfizer

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.